Veru (VERU) Competitors $0.58 -0.05 (-7.89%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VERU vs. NUS, NATR, MED, XERS, EL, IPAR, PBH, HLF, USNA, and AKBAShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Xeris Biopharma (XERS), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), and Akebia Therapeutics (AKBA). Veru vs. Nu Skin Enterprises Nature's Sunshine Products Medifast Xeris Biopharma Estée Lauder Companies Inter Parfums Prestige Consumer Healthcare Herbalife USANA Health Sciences Akebia Therapeutics Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Which has stronger earnings and valuation, NUS or VERU? Nu Skin Enterprises has higher revenue and earnings than Veru. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Veru, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNu Skin Enterprises$1.97B0.19$8.60M-$2.07-3.66Veru$16.30M5.24-$93.15M-$0.48-1.22 Does the MarketBeat Community favor NUS or VERU? Nu Skin Enterprises received 241 more outperform votes than Veru when rated by MarketBeat users. However, 69.67% of users gave Veru an outperform vote while only 64.00% of users gave Nu Skin Enterprises an outperform vote. CompanyUnderperformOutperformNu Skin EnterprisesOutperform Votes51264.00% Underperform Votes28836.00% VeruOutperform Votes27169.67% Underperform Votes11830.33% Does the media prefer NUS or VERU? In the previous week, Nu Skin Enterprises had 1 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nu Skin Enterprises and 3 mentions for Veru. Veru's average media sentiment score of 1.17 beat Nu Skin Enterprises' score of 0.46 indicating that Veru is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nu Skin Enterprises 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Veru 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is NUS or VERU more profitable? Nu Skin Enterprises has a net margin of -5.81% compared to Veru's net margin of -376.38%. Nu Skin Enterprises' return on equity of 5.47% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets Nu Skin Enterprises-5.81% 5.47% 2.46% Veru -376.38%-115.99%-66.94% Do analysts rate NUS or VERU? Nu Skin Enterprises currently has a consensus price target of $8.88, suggesting a potential upside of 17.08%. Veru has a consensus price target of $4.00, suggesting a potential upside of 585.40%. Given Veru's stronger consensus rating and higher probable upside, analysts plainly believe Veru is more favorable than Nu Skin Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Veru 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in NUS or VERU? 82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 1.7% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, NUS or VERU? Nu Skin Enterprises has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Veru has a beta of -0.47, meaning that its share price is 147% less volatile than the S&P 500. SummaryNu Skin Enterprises and Veru tied by winning 9 of the 18 factors compared between the two stocks. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$85.43M$6.53B$5.15B$8.74BDividend YieldN/A8.16%5.18%4.08%P/E Ratio-1.224.9166.6713.57Price / Sales5.24376.691,276.8487.67Price / CashN/A51.2039.7035.24Price / Book2.659.686.475.93Net Income-$93.15M$154.43M$119.73M$225.73M7 Day Performance-20.30%-9.46%-5.13%-1.34%1 Month Performance-32.49%-7.27%-2.71%1.15%1 Year Performance-45.20%28.13%31.08%24.02% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru2.6645 of 5 stars$0.58-7.9%$4.00+585.4%-41.6%$85.43M$16.30M-1.22189Positive NewsNUSNu Skin Enterprises4.0068 of 5 stars$7.22+10.2%N/A-57.3%$358.85M$1.78B-3.493,700NATRNature's Sunshine Products2.9504 of 5 stars$17.43+17.0%N/A-7.1%$322.63M$445.32M19.81814Positive NewsHigh Trading VolumeMEDMedifast2.59 of 5 stars$19.44+1.5%N/A-72.7%$212.53M$674.48M29.45870Positive NewsXERSXeris Biopharma4.0131 of 5 stars$3.28-5.5%N/A+86.0%$488.72M$181.41M-7.29290Analyst RevisionNews CoverageELEstée Lauder Companies4.8029 of 5 stars$64.58+1.1%N/A-48.0%$23.18B$15.61B115.3262,000Short Interest ↑IPARInter Parfums4.4285 of 5 stars$128.80+0.4%N/A-1.8%$4.11B$1.42B27.64530Analyst ForecastShort Interest ↑Analyst RevisionNews CoveragePBHPrestige Consumer Healthcare3.7771 of 5 stars$81.75+1.7%N/A+39.6%$4.05B$1.13B19.89540Insider SellingAnalyst RevisionHLFHerbalife4.0638 of 5 stars$8.67+1.9%N/A-37.6%$873.87M$5.00B10.209,200USNAUSANA Health Sciences2.8527 of 5 stars$41.29+2.6%N/A-11.8%$786.99M$861.97M14.591,800AKBAAkebia Therapeutics4.0701 of 5 stars$1.99+2.6%N/A+81.0%$407.96M$194.62M-8.65167 Related Companies and Tools Related Companies NUS Alternatives NATR Alternatives MED Alternatives XERS Alternatives EL Alternatives IPAR Alternatives PBH Alternatives HLF Alternatives USNA Alternatives AKBA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VERU) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.